Dymista and Hereditary angioedema - a phase IV clinical study of FDA data

Summary:

Hereditary angioedema is reported as a side effect among people who take Dymista (azelastine hydrochloride; fluticasone propionate), especially for people who are female, 50-59 old, also take Heparin, and have Immune system disorder.

The phase IV clinical study analyzes which people have Hereditary angioedema when taking Dymista. It is created by eHealthMe based on reports of 4,296 people who have side effects when taking Dymista from the FDA, and is updated regularly.

What is Dymista?

Dymista has active ingredients of azelastine hydrochloride; fluticasone propionate. It is often used in allergies. eHealthMe is studying from 4,407 Dymista users. Check the latest studies of Dymista.

What is Hereditary angioedema?

Hereditary angioedema (recurrent episodes of severe swelling) is found to be associated with 471 drugs and 546 conditions by eHealthMe. Check the latest studies of Hereditary angioedema.

On Jul, 10, 2026

4,296 people reported to have side effects when taking Dymista.
Among them, 12 people (0.28%) have Hereditary angioedema.

Could Dymista cause Hereditary angioedema?

Among these 12 people:

What is the gender of people who have Hereditary angioedema when taking Dymista? *

female: 100 %
male: 0.0 %

What is the age of people who have Hereditary angioedema when taking Dymista? *

What are other drugs people take besides Dymista? *

What are other side effects people have besides Hereditary angioedema? *

Allergy To Vaccine: 3 people, 25.00%
Lung Disorder (lung disease): 3 people, 25.00%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 3 people, 25.00%
Asthma: 3 people, 25.00%
Infection: 3 people, 25.00%
Limb Injury: 3 people, 25.00%
Weight Increased: 2 people, 16.67%
Wrist Fracture: 2 people, 16.67%
Nerve Injury: 2 people, 16.67%
Procedural Complication: 2 people, 16.67%

What are the existing conditions these people have? *

Secondary Immunodeficiency (lack of immunity due to some disease): 3 people, 25.00%
Immune System Disorder: 3 people, 25.00%
Angioedema (rapid swelling of the dermis): 2 people, 16.67%
Asthma: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Dymista and have Hereditary angioedema?

- Check whether Hereditary angioedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dymista:

Dymista (4,407 reports)

Hereditary angioedema treatments and more:

Hereditary angioedema (22,754 reports)

How severe was Hereditary angioedema and when was it recovered:

Hereditary angioedema in Dymista

Expand to all the drugs that have ingredients of azelastine hydrochloride; fluticasone propionate:

Hereditary angioedema and drugs with ingredients of azelastine hydrochloride; fluticasone propionate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dymista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hereditary angioedema:

Hereditary angioedema (471 drugs)

Browse all the conditions that are associated with Hereditary angioedema:

Hereditary angioedema (546 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on azelastine hydrochloride; fluticasone propionate (the active ingredients of Dymista) and Dymista (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.